Abstract
Purpose
Materials and Methods
Results
Figures and Tables
![]() | Fig. 1A small pulmonary nodule in the right upper lobe of a 47-year-old woman with history of breast cancer.
A. About 1 cm-sized well-marginated, small, round nodule in RUL is noted on the lung setting axial image of the HRCT.
B. CT mean attenuation value is measured using free-drawing ROI on the mediastinal setting of axial image.
C. The nodule was not detected on fluoroscopy performed with the patient in supine position.
D. The operator accordingly performed cone-beam CT guided PTNB with careful adjustment of the needle. The result of PTNB indicated a meta-static adenocarcinoma.
HRCT = high-resolution CT, PTNB = percutaneous transthoracic needle biopsy, ROI = region of interest, RUL = right upper lobe
|
![]() | Fig. 2A solitary pulmonary mass suspicious for malignancy in the right lower lobe of a 72-year-old man, which was well-marginated, irregular-shaped, and abutting the pleura.
A. Antero-posterior diameter of the mass is measured to about 3.61 cm on the unenhanced axial image of the chest CT.
B. CT mean attenuation value is subsequently measured using free-drawing ROI on the unenhanced axial image.
C. Long-axis and short axis diameters are also measured on the coronal reconstructed image.
D. Fluoroscopic image shows the mass with well-defined margin on the left side. The operator next performed fluoroscopy-guided PTNB with patient in prone position and careful adjustment of the needle; the result of PTNB indicated a squamous cell carcinoma.
PTNB = percutaneous transthoracic needle biopsy, ROI = region of interest
|
![]() | Fig. 3Box plots of predicting independent variables in conversion of fluoroscopy guided PTNB to cone-beam CT guided PTNB.
A. Box plot comparing the short-axis diameter, long-axis diameter, and AP diameter of pulmonary lesion between the patients who underwent fluoroscopy-guided PTNB vs. cone-beam CT guided PTNB.
B. Box plot showing CT attenuation value of pulmonary lesion of the above 2 groups.
*, • = outlier.
AP = anterior to posterior, PTNB = percutaneous transthoracic needle biopsy
|
![]() | Fig. 4Receive operating characteristics curve (ROC curve). This graph showed statistically significant independent variables, short-axis diameter and CT attenuation value of the pulmonary lesion. AUC of these variables were 0.753 and 0.722, respectively. We set a cut-off value to 29.50 of CT attenuation that showed 65.8% of sensitivity and specificity, respectively; in addition, we set a cut-off value to 1.65 cm of short-axis diameter that showed 68.4% of sensitivity and 71.1% of specificity.AUC = area under the curve
|
Table 1
Demographics and Image Characteristics between Patients Underwent Fluoroscopy Guided PTNB and Underwent Cone-Beam CT Guided PTNB

Data in parentheses are percentages.
*Data interval means days between CT exam date and PTNB date.
†p value was calculated with the independent sample t test.
‡p value was calculated with the Pearson χ2 test.
§p value was calculated with the Fisher exact test.
PTNB = percutaneous transthoracic needle biopsy
Table 2
Pathologic Results of the Percutaneous Transthoracic Needle Biopsies

Data in parentheses are percentages.
*Metastatic tumors from breast cancer, colorectal cancer, hepatocellular carcinoma, and diffuse large B cell lymphoma.
†Five cases was confirmed by using the VATs biopsy due to failure of PTNB.
AIS = adenocarcinoma in situ (new name for BAC under the new IASLC), BAC = bronchoalveolar carcinoma, CGI = chronic granulomatous inflammation with/without necrosis, IASLC = International Association for the Study of Lung Cancer, NSCI = nonspecific chronic inflammation, PTNB = percutaneous transthoracic needle biopsy, VATs = video assisted thoracoscopy